Routine Prostate Cancer Screening Doesn't Reduce Risk of Death

Routine screening for prostate cancer does not lower the risk of dying from the disease, according to new study results, reigniting the controversy over the benefits of annual testing. In a follow-up to previously reported data, researchers led by Dr. Gerald Andriole, chief of urologic surgery at Washington University School of Medicine in St. Lous, found that men who underwent yearly screening for prostate cancer, which included a digital rectal examination and a blood test for...Full Story
Commenting on this article is closed.